Inhibition of endocytic recycling of ACE2 by SARS-CoV-2 S protein partially explains multiple COVID-19 related diseases caused by ACE2 reduction
- PMID: 35421520
- PMCID: PMC9001010
- DOI: 10.1016/j.jinf.2022.04.019
Inhibition of endocytic recycling of ACE2 by SARS-CoV-2 S protein partially explains multiple COVID-19 related diseases caused by ACE2 reduction
Conflict of interest statement
Declaration of Competing Interest The authors declare that there are no conflicts of interest.
Figures


Comment on
-
Analysis of angiotensin-converting enzyme 2 (ACE2) from different species sheds some light on cross-species receptor usage of a novel coronavirus 2019-nCoV.J Infect. 2020 Apr;80(4):469-496. doi: 10.1016/j.jinf.2020.02.013. Epub 2020 Feb 21. J Infect. 2020. PMID: 32092392 Free PMC article. No abstract available.
References
-
- Lei Y., Zhang J., Schiavon C.R., He M., Chen L., Shen H., Zhang Y., Yin Q., Cho Y., Andrade L., Shadel G.S., Hepokoski M., Lei T., Wang H., Zhang J., Yuan J.X., Malhotra A., Manor U., Wang S., Yuan Z.Y., Shyy J.Y. SARS-CoV-2 spike protein impairs endothelial function via downregulation of ACE2. Circ Res. 2021;128:1323–1326. - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous